Rigaku Introduces On-Demand Video Describing the Performance of New Direct Excitation EDXRF Elemental Analyzer

Applied Rigaku Technologies, Inc. is pleased to introduce the latest in a series of informational product videos. The new video highlights the features and capabilities of the new Rigaku NEX DE high-performance direct excitation energy dispersive X-ray fluorescence (EDXRF) elemental analyzer.

Especially engineered for heavy industrial use, whether on the plant floor or in remote field environments, the NEX DE analyzer was developed to maximize flexibility and ease-of-use. Suitable for a broad range of applications, the instrument was designed for demanding measurements, or for situations where analysis time or sample throughput is critical. It is equipped with a 60 kV, 12 W X-ray tube, delivering significant improvements in elemental peak resolution and counting statistics, to facilitate superior calibrations and precision for the most challenging analyses.

From the different analysis atmospheres supported and its advancement in X-ray tube conservation, to the performance of the X-ray tube and detector, the 3 ½ minute video presentation describes how the Nex DE spectrometer delivers the instrument’s three core requirements of flexibility, sensitivity and reliability.

The video also offers a preview of Rigaku QuantEZ analytical software, developed to be both extraordinarily powerful and extremely easy to use.  QuantEZ™ software, coupled with the high-resolution SDD detector, enables straightforward qualitative evaluation of spectra, as it walks the user through the steps required to set up either an empirical or Fundamental Parameters application.

The video is among the most recent in a collection of product videos available on both the Rigaku company website and Rigaku YouTube channel. It can be seen at

http://www.rigakuedxrf.com/edxrf/nex-de.html.

About Rigaku

Since its inception in Japan in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on general-purpose analytical instrumentation and the life sciences. With hundreds of major innovations to their credit, Rigaku companies are world leaders in X-ray spectrometry, X-ray diffraction, non-destructive testing, X-ray microscopy, Raman spectroscopy and optics, as well as small molecule and protein crystallography and semiconductor metrology. Today, Rigaku employs over 1,100 people in the manufacturing, sales and support of its analytical equipment, which is used in more than 70 countries around the world for research, development, and quality assurance activities. Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial communities. Information about Rigaku is available at www.rigaku.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rigaku Corporation. (2019, February 08). Rigaku Introduces On-Demand Video Describing the Performance of New Direct Excitation EDXRF Elemental Analyzer. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=44218.

  • MLA

    Rigaku Corporation. "Rigaku Introduces On-Demand Video Describing the Performance of New Direct Excitation EDXRF Elemental Analyzer". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=44218>.

  • Chicago

    Rigaku Corporation. "Rigaku Introduces On-Demand Video Describing the Performance of New Direct Excitation EDXRF Elemental Analyzer". AZoM. https://www.azom.com/news.aspx?newsID=44218. (accessed November 21, 2024).

  • Harvard

    Rigaku Corporation. 2019. Rigaku Introduces On-Demand Video Describing the Performance of New Direct Excitation EDXRF Elemental Analyzer. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=44218.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.